Literature DB >> 11866239

Endometrial factors in recurrent miscarriage.

T C Li1, E M Tuckerman, S M Laird.   

Abstract

Recurrent pregnancy loss may be a consequence of an abnormal embryonic karyotype, or maternal factors affecting the endometrium resulting in defective implantation. In order to study the endometrial factors responsible for recurrent pregnancy loss, endometrial biopsy samples should be precisely timed according to the LH surge, and the investigation should be carried out in a non-conception cycle, prior to the next pregnancy. The various methods of studying the endometrium including morphological studies, morphometry, immunohistrochemistry, measurement of endometrial protein in plasma and uterine flushings, cytokine expression in endometrial cells, leukocyte populations in the endometrium and ultrasonographic and hysteroscopic studies, were reviewed. The clinical relevance of the observed abnormality depends on whether or not the abnormality is persistent in subsequent cycles, and if the observed abnormality is of significant prognostic value. Very little is known about the treatment of endometrial defect associated with recurrent pregnancy loss, but preliminary data suggest that the use of HMG may be of benefit.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11866239     DOI: 10.1093/humupd/8.1.43

Source DB:  PubMed          Journal:  Hum Reprod Update        ISSN: 1355-4786            Impact factor:   15.610


  7 in total

1.  Progesterone to prevent miscarriage in women with early pregnancy bleeding: the PRISM RCT.

Authors:  Arri Coomarasamy; Hoda M Harb; Adam J Devall; Versha Cheed; Tracy E Roberts; Ilias Goranitis; Chidubem B Ogwulu; Helen M Williams; Ioannis D Gallos; Abey Eapen; Jane P Daniels; Amna Ahmed; Ruth Bender-Atik; Kalsang Bhatia; Cecilia Bottomley; Jane Brewin; Meenakshi Choudhary; Fiona Crosfill; Shilpa Deb; W Colin Duncan; Andrew Ewer; Kim Hinshaw; Thomas Holland; Feras Izzat; Jemma Johns; Mary-Ann Lumsden; Padma Manda; Jane E Norman; Natalie Nunes; Caroline E Overton; Kathiuska Kriedt; Siobhan Quenby; Sandhya Rao; Jackie Ross; Anupama Shahid; Martyn Underwood; Nirmala Vaithilingham; Linda Watkins; Catherine Wykes; Andrew W Horne; Davor Jurkovic; Lee J Middleton
Journal:  Health Technol Assess       Date:  2020-06       Impact factor: 4.014

2.  Altered endometrial expression of endothelial nitric oxide synthase in women with unexplained recurrent miscarriage and infertility.

Authors:  Tohid Najafi; Marefat Ghaffari Novin; Reza Ghazi; Omid Khorram
Journal:  Reprod Biomed Online       Date:  2012-07-20       Impact factor: 3.828

3.  Gradient Boosting Machine Learning Model for Defective Endometrial Receptivity Prediction by Macrophage-Endometrium Interaction Modules.

Authors:  Bohan Li; Hua Duan; Sha Wang; Jiajing Wu; Yazhu Li
Journal:  Front Immunol       Date:  2022-05-06       Impact factor: 8.786

4.  Apoptosis is increased and cell proliferation is decreased in out-of-phase endometria from infertile and recurrent abortion patients.

Authors:  Gabriela F Meresman; Carla Olivares; Susana Vighi; Margarita Alfie; Marcela Irigoyen; Juan J Etchepareborda
Journal:  Reprod Biol Endocrinol       Date:  2010-10-22       Impact factor: 5.211

5.  Somatic genomic variations in extra-embryonic tissues.

Authors:  Jingly F Weier; Christy Ferlatte; Heinz-Ulli G Weier
Journal:  Curr Genomics       Date:  2010-09       Impact factor: 2.236

6.  Identification of key contributory factors responsible for vascular dysfunction in idiopathic recurrent spontaneous miscarriage.

Authors:  Priyanka Banerjee; Sanghamitra Ghosh; Mainak Dutta; Elavarasan Subramani; Jaydeep Khalpada; Sourav Roychoudhury; Baidyanath Chakravarty; Koel Chaudhury
Journal:  PLoS One       Date:  2013-11-15       Impact factor: 3.240

7.  Hyaluronan-binding protein 2 (HABP2) gene variation in women with recurrent miscarriage.

Authors:  Frida Husseini-Akram; Sally Haroun; Signe Altmäe; Lottie Skjöldebrand-Sparre; Helena Åkerud; Inger Sundström Poromaa; Britt-Marie Landgren; Anneli Stavreus-Evers
Journal:  BMC Womens Health       Date:  2018-08-24       Impact factor: 2.809

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.